Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Dynamically-adaptive live therapeutic agents and methods of use thereof

Patent ·
OSTI ID:1771529
This disclosure provides microbes engineered to detect virulent and spore states of pathogens and release an appropriate therapeutic response accordingly and compositions and methods of use of the same.
Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-07NA27344
Assignee:
Lawrence Livermore National Security, LLC (Livermore, CA)
Patent Number(s):
10,808,232
Application Number:
15/438,638
OSTI ID:
1771529
Country of Publication:
United States
Language:
English

References (11)

Engineering microbes to sense and eradicate Pseudomonas aeruginosa , a human pathogen journal January 2011
Tuning Response Curves for Synthetic Biology journal September 2013
Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform journal September 2014
Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores journal February 2008
Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen journal September 2014
Functional roles for noise in genetic circuits journal September 2010
Genetically Programmable Pathogen Sense and Destroy journal July 2013
Clostridium difficile Has Two Parallel and Essential Sec Secretion Systems journal June 2011
Nontoxigenic Clostridium difficile Protects Hamsters against Challenge with Historic and Epidemic Strains of Toxigenic BI/NAP1/027 C. difficile journal August 2013
Clostridium difficile—A continually evolving and problematic pathogen journal December 2009
Clostridium difficile spore biology: sporulation, germination, and spore structural proteins journal July 2014

Similar Records

Related Subjects